Senior Director, Pipeline & Product Communications

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. The Opportunity: The Senior Director, Pipeline & Product Communications will lead the strategy, development, and execution of integrated communications across the company’s pipeline and product candidate portfolio. This role is accountable for shaping how Revolution Medicines’ pipeline and product narratives are understood by external stakeholders, including scientific and medical audiences, patients and advocates, media, and the broader healthcare ecosystem. Reporting to the Head of Communications, this leader will serve as a trusted strategic advisor to cross-functional partners across R&D, Medical Affairs, Regulatory, Commercial, Market Access, Patient Advocacy, Legal, and Investor Relations. The role requires deep expertise across the full product lifecycle, from early clinical development through regulatory milestones and launch readiness, and the ability to translate complex science into clear, differentiated, and credible narratives. This is a high-impact leadership role for a communications professional who thrives at the intersection of science, strategy, people leadership, and reputation management. Key Responsibilities include but not limited to: Own and lead the integrated pipeline and product communications strategy across all stages of development, ensuring clear differentiation, scientific credibility, and alignment with corporate and business priorities. Direct communications for major clinical and regulatory milestones, including data readouts, congress presentations, trial initiations, filings, approvals, and pre-launch milestones, in close partnership with R&D, Medical Affairs, Regulatory, and Legal. Serve as the senior communications advisor for launch readiness, shaping pre-launch and launch narratives across earned media, disease education, patient engagement, and stakeholder communications, with clear linkage to future commercial strategy. Lead disease awareness and patient advocacy communications, ensuring responsible education, strong patient advocacy group partnerships, and integration of patient voice into pipeline and product storytelling. Provide strategic counsel on value, access, and product-related issues, anticipating reputational risk and leading communications response to safety updates, competitive dynamics, and external scrutiny. Drive scientific and medical thought leadership, positioning Revolution Medicines and its leaders as credible voices through publications, congress presence, executive visibility, and media engagement. Build and lead a high-performing pipeline and product communications team, setting direction, developing talent, and ensuring consistent, high-quality execution. Oversee agency partners and measurement frameworks, using insights to evaluate impact, optimize performance, and scale communications effectiveness. Required Skills, Experience and Education: The successful candidate will be a seasoned communications leader with a proven track record of building and leading integrated pipeline and product communications strategies in complex, science-driven organizations. 15+ years of experience in biotech or pharmaceutical communications, including deep experience in pipeline and product communications in-house and/or at a leadi